Search

Clinical Articles / BY: Darlene M.S. Hammell, MD October 2001
... disease (CHD) is the leading cause of death in women. [ 1]  It also contributes a significant burden of morbidity. ... such negative outcomes as breast cancer appeared small (RR 1.32 for estrogen alone; RR 1.41 for estrogen plus progestin) when applied to the ...
Clinical Articles / BY: R.C. Offer, MD, FRCPC, FACR October 2001
... costs of osteoporosis in Canada were estimated to be $1.3 billion. [ 1]  Increasing longevity and rising numbers of aging baby ... review of the woman’s lifestyle and risk factors ( Table 1 ). Modification of these risks, where possible, is ...
Clinical Articles / BY: Suzanne Montemuro, MD, CCFP October 2001
... information in order to make informed health decisions. [1] Physicians have the opportunity to play a key role in the ... may be quite disabling for 30% of menopausal women ( Table 1 ). Symptoms of menopause may last from a few months to ... replacement therapy (HRT) will arise. A brief period (1 month) off OCT followed by a serum follicle-stimulating ...
College Library / BY: Jim Henderson October 2001
... is US$71 plus GST, approximately $120, from ACP–ASIM at 1 800 523-1546. The Library has a number of sample issues for ...
Editorials / BY: Vera Frinton, MD October 2001
... Faculty of Medicine, UBC Editorials Menopause, Part 1—Women shifting gears (Guest editorial) ...
Clinical Articles / BY: B. Strauss, RN, BScN, MSc November 2001
... a marked reduction in the incidence of these diseases. [ 1]  However, several published reports have questioned the ... (RI) 0.94 [95% confidence interval (CI) = 0.60– 1.47]) and there was no temporal clustering between onset of autism and MMR vaccination within the following 1 to 2 years (RI 1.09 [95% CI = 0.76–1.52]). Furthermore, ...
Clinical Articles / BY: Timothy C. Rowe, MBBS, FRCSC, FRCOG November 2001
... may themselves affect morbidity differently. [ 1] What are the options? Estrogens Estrogens may be ... transdermally, vaginally, or by injection (see  Table 1 ). Only oral conjugated estrogens are a Pharmacare benefit ... or Kliofem. This contains 2 mg of 17ß-estradiol and 1 mg of norethindrone acetate in each daily dose. Clinical ...
Clinical Articles / BY: Karen A. Gelmon, MD, FRCPC November 2001
... risk by opposing estrogenic stimulation of the breast [ 1]  and increase risk by increasing breast mitotic rates. [ ... used HRT have a small increased relative risk ranging from 1.01 to 1.14. The “ever used” category, however, fails to ...
Clinical Articles / BY: Margo R. Fluker, MD, FRCSC November 2001
... either estrogen alone or estrogen plus a progestin. [ 1]  In recent years, standard teaching suggested that HRT ... duration of HRT. In such a model, HRT might be used for 1 to 5 years in the perimenopausal interval to control ... and aging. Vasomotor symptoms Vasomotor symptoms ( Table 1 ) are usually most troublesome in the perimenopause and ...
Clinical Articles November 2001
... for “Exposure to Biological Agents Response Plan”  [1]   to assist medical health officers and other regional ... (e.g., household 5% bleach, diluted 10 parts water to 1 part bleach) and finally rinsed with water to minimize skin ...